| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 133, 728-740, Copyright © 1993 by Endocrine Society
ARTICLES |
CA Beck, PA Estes, BJ Bona, CA Muro-Cacho, SK Nordeen and DP Edwards
Department of Pathology, University of Colorado Health Sciences Center, Denver 80262.
To determine whether the steroid antagonist RU486 mediates its antiglucocorticoid and antiprogestin activities by the same or different receptor mechanisms, a direct comparison of RU486 interaction with glucocorticoid (GR) and progesterone (PR) receptors was made. The effects of RU486 on transformation of GR and PR 8-10S complexes in the intact cell and in vitro were analyzed by sucrose density gradient centrifugation, and the in vitro stability of receptor-heat shock protein-90 interactions was analyzed by coimmunoprecipitation. Compared to agonist, RU486 binding produced a reduction in the amount of GR converted from 8S to 4S and stabilized the GR-heat shock protein-90 complex. By contrast, PR-RU486 complexes were transformed both in vitro and in the intact cell to the same extent as receptor-agonist complexes. PR-RU486 complexes sedimented at 5-6S, whereas PR-R5020, GR- RU486, and GR-agonist complexes sedimented at 4S. The portion of GR that undergoes nuclear transformation when bound to RU486 was examined for binding to the glucocorticoid-progesterone response element of the mouse mammary tumor virus by an immunoprecipitation assay. The nuclear- transformed GR-RU486 complex bound the glucocorticoid-progesterone response element with the same affinity as the nuclear-transformed GR- triamcinolone acetonide complex. The electrophoretic mobilities of GR- RU486 complexes and GR-agonist complexes were the same, as determined by gel retardation assay. These results suggest that RU486 exerts its antiglucocorticoid activity at two levels of receptor action: prevention of complete GR transformation and alteration of a step subsequent to GR-DNA binding. As an antiprogestin, RU486 action is exerted predominantly at a post-DNA-binding step.
This article has been cited by other articles:
![]() |
L. J Martin and J. J Tremblay Glucocorticoids antagonize cAMP-induced Star transcription in Leydig cells through the orphan nuclear receptor NR4A1 J. Mol. Endocrinol., September 1, 2008; 41(3): 165 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. D. Weber, S. A. Madsen-Bouterse, G. J. M. Rosa, S. Sipkovsky, X. Ren, P. E. Almeida, R. Kruska, R. G. Halgren, J. L. Barrick, and J. L. Burton Analysis of the bovine neutrophil transcriptome during glucocorticoid treatment Physiol Genomics, December 13, 2006; 28(1): 97 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Lu, P.-Y. Yeh, S.-E. Chuang, M. Gao, M.-L. Kuo, and A.-L. Cheng Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa J. Endocrinol., February 1, 2006; 188(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Garside, A. Stevens, S. Farrow, C. Normand, B. Houle, A. Berry, B. Maschera, and D. Ray Glucocorticoid Ligands Specify Different Interactions with NF-{kappa}B by Allosteric Effects on the Glucocorticoid Receptor DNA Binding Domain J. Biol. Chem., November 26, 2004; 279(48): 50050 - 50059. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Dong, A. Salva, C. M. Sottas, E. Niu, M. Holmes, and M. P. Hardy Rapid Glucocorticoid Mediation of Suppressed Testosterone Biosynthesis in Male Mice Subjected to Immobilization Stress J Androl, November 1, 2004; 25(6): 973 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Necela and J. A. Cidlowski A Single Amino Acid Change in the First Zinc Finger of the DNA Binding Domain of the Glucocorticoid Receptor Regulates Differential Promoter Selectivity J. Biol. Chem., September 17, 2004; 279(38): 39279 - 39288. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.D. Catalano, A. Yanaihara, A.L. Evans, D. Rocha, A. Prentice, S. Saidi, C.G. Print, D.S. Charnock-Jones, A.M. Sharkey, and S.K. Smith The effect of RU486 on the gene expression profile in an endometrial explant model Mol. Hum. Reprod., August 1, 2003; 9(8): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schwarzenbach, P. R. Manna, D. M. Stocco, G. Chakrabarti, and A. K. Mukhopadhyay Stimulatory Effect of Progesterone on the Expression of Steroidogenic Acute Regulatory Protein in MA-10 Leydig Cells Biol Reprod, March 1, 2003; 68(3): 1054 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Kim, Y. Kang, S. E. Choi, J. H. Kim, H. M. Kim, B. Sun, H.-S. Jun, and J.-W. Yoon Modulation of Glucocorticoid-Induced GAD Expression in Pancreatic {beta}-Cells by Transcriptional Activation of the GAD67 Promoter and Its Possible Effect on the Development of Diabetes Diabetes, September 1, 2002; 51(9): 2764 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Spencer, P. J. Kim, B. A. Kalman, and M. A. Cole Evidence for Mineralocorticoid Receptor Facilitation of Glucocorticoid Receptor-Dependent Regulation of Hypothalamic-Pituitary-Adrenal Axis Activity Endocrinology, June 1, 1998; 139(6): 2718 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wiedemann, C. J. Lauer, M. Hirschmann, K. Knaudt, and F. Holsboer Sleep-endocrine effects of mifepristone and megestrol acetate in healthy men Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E139 - E145. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Beck, Y. Zhang, M. Altmann, N. L. Weigel, and D. P. Edwards Stoichiometry and Site-specific Phosphorylation of Human Progesterone Receptor in Native Target Cells and in the Baculovirus Expression System J. Biol. Chem., August 9, 1996; 271(32): 19546 - 19555. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Kuil, C. A. Berrevoets, and E. Mulder Ligand-induced Conformational Alterations of the Androgen Receptor Analyzed by Limited Trypsinization J. Biol. Chem., November 17, 1995; 270(46): 27569 - 27576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J S Mymryk and T K Archer Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo. Genes & Dev., June 1, 1995; 9(11): 1366 - 1376. [Abstract] [PDF] |
||||
![]() |
B van Steensel, M Brink, K van der Meulen, E. van Binnendijk, D. Wansink, L de Jong, E. de Kloet, and R van Driel Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus J. Cell Sci., January 9, 1995; 108(9): 3003 - 3011. [Abstract] [PDF] |
||||
![]() |
C. Massaad, M. Paradon, C. Jacques, C. Salvat, G. Bereziat, F. Berenbaum, and J.-L. Olivier Induction of Secreted Type IIA Phospholipase A2 Gene Transcription by Interleukin-1beta . ROLE OF C/EBP FACTORS J. Biol. Chem., July 21, 2000; 275(30): 22686 - 22694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |